News coverage about Mindray Medical International (NYSE:MR) has been trending positive this week, Accern Sentiment reports. The research group rates the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Mindray Medical International earned a daily sentiment score of 0.26 on Accern’s scale. Accern also gave media coverage about the medical instruments supplier an impact score of 46.7151240038493 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Shares of Mindray Medical International (NYSE MR) remained flat at $27.94 during midday trading on Monday. Mindray Medical International has a one year low of $21.80 and a one year high of $33.83. The company has a 50 day moving average price of $27.20 and a 200-day moving average price of $25.81.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/08/21/mindray-medical-international-mr-earning-positive-news-coverage-report-shows.html.

About Mindray Medical International

Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature.

Insider Buying and Selling by Quarter for Mindray Medical International (NYSE:MR)

Receive News & Stock Ratings for Mindray Medical International Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindray Medical International Ltd and related stocks with our FREE daily email newsletter.